Prescription ID | TCMF5435 |
Pinyin Name | Qing Nao An Shen Wan |
Chinese Name | 清脑安神丸 |
English Name | Qing Nao An Shen Pills |
Function Description | 惊悸, 怔仲, 不寐, 健忘, 眩晕, 耳鸣 |
Indications | Inducible palpitation disorder, Tinnitus disorder, Vertigo disorder, Forgetfulness disorder, Insomnia disorder, Insomnia, Tinnitus, Dizziness |
Disease ICD-11 Category |
SA10 [Inducible palpitation disorder (TM1), 惊悸 (TM1)
]; SC75 [Tinnitus disorder (TM1), 耳鸣 (TM1) ]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD23 [Forgetfulness disorder (TM1), 健忘 (TM1) ]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; 7A0Z [Insomnia disorders, unspecified, 失眠障碍,未特指的 ]; MC41 [Tinnitus, 耳鸣 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; |
Human Tissues Associated with Indication | Brain, Heart |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH2554 | Polygala tenuifolia | 远志 | TCMH2554 | MF096619 |
TCMH916 | Succinus | 琥珀 | TCMH916 | |
TCMH1525 | Crassostrea gigas | 牡蛎 | TCMH1525 | BCMOL364-12 |
TCMH324 | Magnetitum | 磁石 | TCMH324 | |
TCMH2202 | Schisandra chinensis | 五味子 | TCMH2202 | ITSAM2867-14 |
TCMH305 | Cnidium officinale | 川芎 | TCMH305 | ITSAP4207-14 |
TCMH1181 | Chrysanthemum morifolium | 菊花 | TCMH1181 | KX675020 |
TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
TCMH1321 | Os draconis | 龙骨 | TCMH1321 | |
TCMH1163 | Rhizoma anemones altaicae | 九节菖蒲 | TCMH1163 | |
TCMH451 | Rehmannia glutinosa | 地黄 | TCMH451 | ITSAH4578-14 |
TCMH407 | Salvia miltiorrhiza | 丹参 | TCMH407 | ITSAH2408-14 |
TCMH1423 | Ophiopogon japonicus | 麦冬 | TCMH1423 | ITSAJ4140-14 |
TCMH628 | Glycyrrhiza uralensis | 甘草 | TCMH628 | ITSAM892-14 |
TCMH2551 | Polygonatum odoratum | 玉竹 | TCMH2551 | ITSAM921-14 |
TCMH2641 | Gardenia jasminoides | 栀子 | TCMH2641 | ITSAJ4473-14 |
TCMH986 | Scutellaria baicalensis | 黄芩 | TCMH986 | ITSAP4211-14 |
TCMH1963 | Caulis polygoni multiflori | 首乌藤 | TCMH1963 | |
TCMH2078 | Acacia concinna | 藤合欢 | TCMH2078 | GBVP7225-15, GBVP6411-15 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT171 | PTPN6 | Protein-tyrosine phosphatase 1C | Hydrolase | P29350 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
TCMT207 | BACE1 | Beta-secretase 1 | Protease | P56817 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT210 | CES2 | Carboxylesterase 2 | Hydrolase | O00748 |
TCMT211 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | Transferase | P23141 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT231 | GBA2 | Beta-glucosidase | Hydrolase | Q9HCG7 |
TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
TCMT233 | PTPN11 | Protein-tyrosine phosphatase 2C | Hydrolase | Q06124 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT247 | ADRA2A | Alpha-2a adrenergic receptor | GPCR | P08913 |
TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT283 | PTPRS | Receptor-type tyrosine-protein phosphatase S | Hydrolase | Q13332 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT302 | HMGCR | HMG-CoA reductase | Oxidoreductase | P04035 |
TCMT304 | MMP14 | Matrix metalloproteinase 14 | Hydrolase | P50281 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT307 | KCNH2 | HERG | Ion channel | Q12809 |
TCMT31 | CYP2C19 | Cytochrome P450 2C19 | Oxidoreductase | P33261 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
TCMT332 | AOC3 | Amine oxidase, copper containing | Oxidoreductase | Q16853 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT359 | FYN | Tyrosine-protein kinase FYN | Kinase | P06241 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
TCMT510 | KIT | Stem cell growth factor receptor | Kinase | P10721 |
TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT567 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 | Transferase | P26358 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT633 | SLC6A4 | Serotonin transporter | Transporter | P31645 |
TCMT634 | SLC6A2 | Norepinephrine transporter | Transporter | P23975 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
TCMT751 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Kinase | Q13627 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT771 | ATR | Serine-protein kinase ATR | Kinase | Q13535 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT801 | TUBB3 | Tubulin beta-3 chain | Unclassified | Q13509 |
TCMT807 | SLC22A12 | Solute carrier family 22 member 12 | Transporter | Q96S37 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT81 | ALOX12 | Arachidonate 12-lipoxygenase | Oxidoreductase | P18054 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT884 | PHF8 | Histone lysine demethylase PHF8 | Oxidoreductase | Q9UPP1 |
TCMT907 | FDPS | Farnesyl diphosphate synthase | Lyase | P14324 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
TCMT965 | KDM7A | Lysine-specific demethylase 7 | Oxidoreductase | Q6ZMT4 |
Target ID | Target Name |
---|---|
TCMT1168 | Trichomonas vaginalis |
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1186 | Plasmodium yoelii yoelii |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1191 | Bacillus megaterium |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1224 | Proteus mirabilis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1234 | Bacillus coagulans |
TCMT1235 | Clostridium sporogenes |
TCMT1236 | Mycobacterium bovis |
TCMT1237 | Mycobacterium kansasii |
TCMT1238 | Mycobacterium xenopi |
TCMT1239 | Mycobacterium marinum |
TCMT1243 | Aspergillus flavus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1250 | Vesicular stomatitis virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1260 | Streptococcus agalactiae |
TCMT1282 | Colletotrichum orbiculare |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1296 | Influenza A virus H3N2 |
TCMT1319 | Corynebacterium xerosis |
TCMT1321 | Staphylococcus hominis |
TCMT1322 | Streptococcus mitis |
TCMT1323 | Corynebacterium pseudodiphtheriticum |
TCMT1324 | Corynebacterium diphtheriae |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1393 | Vibrio sp. |
TCMT1405 | Penicillium citrinum |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1410 | Listeria monocytogenes |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1457 | Leishmania major |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, FABP3, FABP4, FDPS, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MET, PPARA, TRPV1 | 15.265 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, ESR1, FDPS, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 14.0052 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 13.0094 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, FABP3, FDPS, FUT7, GBA2, GLO1, HMGCR, PIM1, PPARA, TYR, XDH | 12.4248 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.9559 |
[BP] GO:0042221 | response to chemical | ABCB1, ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, KIT, MMP2, MMP9, NR3C1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR | 10.5785 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.172 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP2, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 9.8826 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, HMGCR, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PPARA, RORC, SLC6A4, SRC, TRPV1, TYR | 9.57577 |
[BP] GO:0010033 | response to organic substance | ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP2, NR3C1, PPARA, RORC, SLC6A4, SRC, TRPV1, TYR | 9.17573 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 9.12566 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, FABP3, FABP4, FDPS, FUT7, GBA2, HMGCR, KIT, MET, PPARA | 9.07698 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PHF8, TYR, XDH | 8.89947 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR | 8.85881 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 8.85881 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 8.65017 |
[BP] GO:0065008 | regulation of biological quality | ABCB1, ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KCNH2, KDR, KIT, MET, PPARA, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TRPV1, XDH | 8.54777 |
[BP] GO:0009719 | response to endogenous stimulus | ADRA2A, AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, KIT, MMP2, NR3C1, PPARA, SLC6A4, SRC, TRPV1 | 8.12413 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 8.03096 |
[BP] GO:0009725 | response to hormone | ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, KIT, NR3C1, PPARA, SLC6A4, SRC, TRPV1 | 7.96547 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HCAR2, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 7.8512 |
[BP] GO:0070887 | cellular response to chemical stimulus | ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, KIT, MMP2, MMP9, NR3C1, RORC, SLC6A4, SRC, TERT, TRPV1 | 7.45369 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, NR3C1, RORC, SLC6A4, SRC, TYR | 7.33403 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PPARA | 7.33282 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, NR3C1, RORC, SLC6A4, SRC, TRPV1, TYR | 7.30439 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DNMT1, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, SLC6A4, SRC, TERT, XDH | 7.26473 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 7.14189 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 7.02416 |
[BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 7.00758 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, SRC, TERT | 6.8105 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CES1, CYP19A1, CYP3A4, FDPS, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 6.8105 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 6.7079 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC, TERT, TOP2A, TRPV1, XDH | 6.62515 |
[BP] GO:0032787 | None | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GBA2, GLO1, PPARA | 6.62515 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, TOP2A, TRPV1, XDH | 6.62126 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, APP, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, FDPS, GBA2, HMGCR, TYR | 6.55901 |
[BP] GO:0071310 | cellular response to organic substance | ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DNMT1, ESR1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, NR3C1, RORC, SLC6A4, SRC, TRPV1 | 6.49636 |
[BP] GO:0042493 | response to drug | ABCB1, AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, FABP3, HMGCR, HSD11B2, KCNH2, KDR, NR3C1, SLC6A2, SLC6A4, SRC, TRPV1 | 6.48864 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 6.48816 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 6.47289 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PHF8, PIM1, PPARA, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS2, TOP2A, TYR | 6.32343 |
[BP] GO:0006805 | xenobiotic metabolic process | CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP3A4, RORC | 6.0156 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 5.97708 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 5.94417 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, MMP12, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.91189 |
[BP] GO:0015711 | organic anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 | 5.63368 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HCAR2, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, MMP12, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.6106 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.48055 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, TOP2A, TRPV1, XDH | 5.48048 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.42717 |
[BP] GO:0050896 | response to stimulus | ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA6, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, KIT, MMP12, MMP2, MMP9, NR3C1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TRPV1, TYR | 5.31676 |
[BP] GO:0008284 | positive regulation of cell proliferation | ADRA2A, AKR1B1, ALOX12, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, TERT | 5.30944 |
[BP] GO:0051716 | cellular response to stimulus | ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, KIT, MMP2, MMP9, NR3C1, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TRPV1 | 5.14024 |
[BP] GO:0032879 | regulation of localization | ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, F3, HCAR2, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT, TRPV1 | 5.13778 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ADRA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PHF8, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.12221 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX12, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, FDPS, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.0557 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT | 5.05447 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, HCAR2, HMGCR, KDR, SRC, TNKS, TNKS2, TRPV1 | 5.03157 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 | 5.02375 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ADRA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PHF8, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 4.95616 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT | 4.86106 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX12, ALOX15, CES1, CYP19A1, CYP3A4, FDPS, HMGCR, TYR | 4.8268 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GBA2, GLO1, PIM1, PPARA, TYR | 4.80994 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HMGCR, HSD11B2, HSD17B2, IGF1R, KCNH2, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TNKS2, TRPV1, TYR | 4.76939 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ADRA2A, ALOX15, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PHF8, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 4.76549 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, APP, CYP1A1, CYP1B1, ESR1, FLT3, NR3C1, RORC, SLC6A4, SRC, TRPV1 | 4.76217 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC, TERT | 4.76217 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, KIT, PHF8, PPARA, PTPRS, SRC, TYR | 4.76217 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT | 4.76217 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DYRK1A, ESR1, KIT, PPARA, RORC, SLC6A4, SRC, TOP2A | 4.76217 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ADRA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PHF8, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 4.74083 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2C19 | 4.71588 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, ADRA2A, CYP1A1, FABP3, FDPS, FLT3, HCAR2, HMGCR, KIT, PPARA, RORC, SRC | 4.64611 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT | 4.64108 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, FDPS, HMGCR | 4.62775 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT | 4.62775 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, PPARA, RORC, SRC | 4.62548 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC | 4.50687 |
[BP] GO:0006820 | anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 | 4.4219 |
[BP] GO:0042738 | exogenous drug catabolic process | CYP1A2, CYP2A6, CYP2C19, CYP3A4 | 4.39276 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, HMGCR, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 4.31146 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GBA2, GLO1, PIM1, PPARA, TYR | 4.27231 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC | 4.23479 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, APP, AXL, CDK6, CYP1B1, DNMT1, ESR1, IGF1R, MMP2, MMP9, NR3C1, RORC, SLC6A4, SRC, TRPV1 | 4.22229 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CES1, CYP1A1, CYP1B1, HMGCR, KDR, SLC6A4, SRC | 4.22207 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH | 4.20873 |
[BP] GO:0032845 | None | ADORA1, ADRA2A, BCL2, HMGCR, SRC, TNKS, TNKS2, TRPV1 | 4.20394 |
[BP] GO:0006082 | organic acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GBA2, GLO1, PIM1, PPARA, TYR | 4.18214 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.15761 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH | 4.1142 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FDPS, FLT3, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH | 4.07981 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AOX1, AURKB, BACE1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, SRC, XDH | 4.05487 |
[BP] GO:0080134 | regulation of response to stress | ABCB1, ADORA1, ADRA2A, ALOX12, APP, CDK6, CYP19A1, DYRK1A, ESR1, F3, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, PTPRS, SRC, TERT, XDH | 3.99834 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, FDPS | 3.96107 |
[BP] GO:0009987 | cellular process | ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HCAR2, HMGCR, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TUBB3, TYR, XDH | 3.94221 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CDK6, CYP1B1, KCNH2, KDR, NR3C1, SRC, TRPV1 | 3.923 |
[BP] GO:0030335 | positive regulation of cell migration | ADRA2A, ALOX12, APP, BCL2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT | 3.83274 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC | 3.76052 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FDPS, FLT3, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH | 3.72865 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KCNH2, KDR, KIT, MET, PIM1, SRC, TNKS | 3.72283 |
[BP] GO:2000147 | positive regulation of cell motility | ADRA2A, ALOX12, APP, BCL2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT | 3.68778 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT | 3.57097 |
[BP] GO:0051272 | positive regulation of cellular component movement | ADRA2A, ALOX12, APP, BCL2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT | 3.57097 |
[BP] GO:2001300 | lipoxin metabolic process | ALOX12, ALOX15, ALOX5 | 3.53015 |
[BP] GO:0016098 | monoterpenoid metabolic process | CYP1A2, CYP2C19, CYP3A4 | 3.53015 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, F3, FLT3, HMGCR, KDR, KIT, MET, PTPN1, SRC, XDH | 3.50453 |
[BP] GO:0010038 | response to metal ion | ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, TERT | 3.48834 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC | 3.451 |
[BP] GO:0040017 | positive regulation of locomotion | ADRA2A, ALOX12, APP, BCL2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT | 3.43655 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC | 3.40528 |
[BP] GO:0071495 | cellular response to endogenous stimulus | ADRA2A, AKR1B1, APEX1, APP, DNMT1, ESR1, FLT3, IGF1R, KIT, MMP2, NR3C1, SLC6A4, SRC, TRPV1 | 3.37693 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HMGCR, HSD11B2, KIT, MMP2, PPARA, SLC6A4, SRC, TERT, TRPV1, TYR | 3.36312 |
[BP] GO:0042592 | homeostatic process | ADORA1, ADRA2A, AKR1B1, ALOX12, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, SRC, TERT, TRPV1 | 3.35887 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ADRA2A, ALOX12, ALOX15, BCL2, CDK6, CYP19A1, DYRK1A, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, PTPRS, SRC, TERT, XDH | 3.35887 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT | 3.35181 |
[BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.32705 |
[BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.32705 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, HMGCR, KDR, KIT, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 3.32175 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT | 3.264 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.23782 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 | 3.23007 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, KIT, MMP9, PHF8, PIM1, PPARA, PTPRS, RORC, SRC, TYR | 3.21035 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT | 3.18949 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, XDH | 3.10972 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, ADRA2A, ALOX12, APP, AXL, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, HCAR2, HMGCR, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIM1, PTPRS, SLC6A4, SRC, TERT, TNKS2, TRPV1, XDH | 3.01637 |
[BP] GO:0034502 | protein localization to chromosome | AURKB, ESR1, TERT, TNKS, TNKS2 | 3.00053 |
[BP] GO:0070988 | demethylation | APEX1, CYP1A1, CYP1A2, CYP3A4, PHF8 | 3.00053 |
[BP] GO:0051050 | positive regulation of transport | ABCB1, ACHE, ADORA1, ADRA2A, APP, AXL, BCL2, CA2, CYP19A1, HCAR2, KCNH2, MMP12, SLC6A4, SRC, TERT, TRPV1 | 3.00053 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT | 2.99639 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 2.93578 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, APP, DNMT1, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, SLC6A4, SRC, TRPV1, TYR | 2.91918 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 2.88498 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC | 2.88498 |
[BP] GO:0048583 | regulation of response to stimulus | ABCB1, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH | 2.87017 |
[BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7 | 2.87017 |
[BP] GO:2001251 | None | DNMT1, PHF8, SRC, TNKS, TNKS2, TOP2A | 2.82398 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CDK6, CES1, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, KDR, KIT, MET, MMP2, MMP9, PTPRS, RORC, SRC, TERT, TOP2A | 2.77089 |
[BP] GO:0002320 | lymphoid progenitor cell differentiation | BCL2, FLT3, KIT | 2.74054 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC | 2.72845 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR | 2.7113 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, ADRA2A, APEX1, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TRPV1, XDH | 2.68619 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | ADRA2A, ALOX12, APP, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIM1, SRC, TERT, TRPV1 | 2.68429 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KCNH2, KDR, KIT, MET, PIM1, SRC, TNKS | 2.67962 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, ADRA2A, BCL2, DYRK1A, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH | 2.65309 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, ADRA2A, BCL2, DYRK1A, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH | 2.64101 |
[BP] GO:0009115 | None | AOX1, XDH | 2.64101 |
[BP] GO:2001301 | lipoxin biosynthetic process | ALOX12, ALOX15 | 2.64101 |
[BP] GO:2001302 | lipoxin A4 metabolic process | ALOX12, ALOX15 | 2.64101 |
[BP] GO:2001303 | lipoxin A4 biosynthetic process | ALOX12, ALOX15 | 2.64101 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS | 2.63983 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DYRK1A, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A, TYR, XDH | 2.63398 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ADRA2A, ALOX15, APP, FLT3, HMGCR, KDR, KIT, PTPN1, SRC, XDH | 2.61487 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, APP, DNMT1, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, SLC6A4, SRC, TRPV1, TYR | 2.61457 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.55624 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, HMGCR, MMP2, MMP9, TERT | 2.55311 |
[BP] GO:0051049 | regulation of transport | ABCB1, ACHE, ADORA1, ADRA2A, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, HCAR2, HMGCR, KCNH2, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT, TRPV1 | 2.5421 |
[BP] GO:0002521 | leukocyte differentiation | AXL, BCL2, FLT3, FUT7, GLO1, KIT, MMP9, RORC | 2.5421 |
[BP] GO:0016125 | None | APP, CES1, CYP19A1, CYP1B1, FDPS, HMGCR | 2.53663 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS | 2.52432 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CYP1A1, HMGCR, HSD11B2, SLC6A4, SRC, TRPV1, TYR | 2.51388 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4 | 2.50348 |
[BP] GO:1901652 | response to peptide | AKR1B1, APEX1, APP, FABP3, HSD11B2, IGF1R, PPARA, SRC, TRPV1 | 2.47165 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.47161 |
[BP] GO:0044283 | None | AKR1B1, ALOX12, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, CYP3A4, FDPS, HMGCR | 2.46289 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH | 2.39801 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH | 2.39801 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, KIT, MMP2, MMP9, SLC6A4, SRC, TOP2A | 2.39686 |
[BP] GO:0006066 | None | AKR1B1, AKR1B10, APP, CES1, CYP1B1, CYP3A4, FDPS, HMGCR | 2.39403 |
[BP] GO:0070198 | None | TERT, TNKS, TNKS2 | 2.39013 |
[BP] GO:1901989 | None | APEX1, APP, CDC25B, CYP1A1, TERT | 2.37517 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH | 2.36585 |
[BP] GO:0006352 | DNA-templated transcription, initiation | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 2.35814 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, KIT, SRC | 2.35814 |
[BP] GO:0008283 | cell proliferation | ABCB1, ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, KIT, MET, PIM1, SRC, TYR | 2.35715 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 2.33905 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, KDR, SRC, TRPV1 | 2.32782 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.3225 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX12, ALOX15, ALOX5 | 2.3225 |
[BP] GO:0046165 | None | AKR1B1, CES1, CYP3A4, FDPS, HMGCR | 2.27546 |
[BP] GO:0009891 | positive regulation of biosynthetic process | APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, NR3C1, PHF8, PPARA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 | 2.2663 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.25333 |
[BP] GO:0046110 | None | AOX1, XDH | 2.25333 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.25333 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | ADRA2A, APEX1, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HMGCR, IGF1R, MET, MMP12, MMP9, NR3C1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TRPV1, XDH | 2.21963 |
[BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, FLT3, HSD11B2, NR3C1, SRC | 2.2187 |
[BP] GO:0016137 | None | AKR1B1, AKR1B10, GBA2 | 2.19435 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, APP, BACE1, CA2, CA7, KIT, SLC6A4 | 2.18853 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, APP, BACE1, CA2, CA7, KIT, SLC6A4 | 2.18853 |
[BP] GO:0045934 | None | ADRA2A, APEX1, AURKB, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, MMP12, NR3C1, PPARA, RORC, SRC, TERT, TNKS, TNKS2, TRPV1 | 2.16596 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, FLT3, HSD11B2, NR3C1, SRC | 2.16165 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AURKB, AXL, BCL2, DNMT1, ESR1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 | 2.15404 |
[BP] GO:0006811 | None | ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, KCNH2, PPARA, SLC6A2, SLC6A4, TRPV1 | 2.15202 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APEX1, APP, DNMT1, IGF1R, MMP2, SLC6A4, SRC, TRPV1 | 2.14542 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.14153 |
[BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | APP, AURKB, DNMT1, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, MMP12, NR3C1, PHF8, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A | 2.12521 |
[BP] GO:0050730 | None | ADORA1, ADRA2A, APP, FLT3, KIT, PTPN1, SRC | 2.10241 |
[BP] GO:0050994 | None | ADORA1, ADRA2A, HCAR2, PPARA | 2.10175 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC | 2.09115 |
[BP] GO:0031667 | response to nutrient levels | ALPL, BCL2, CYP1A1, HMGCR, HSD11B2, SLC6A4, SRC, TRPV1, TYR | 2.07877 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.07877 |
[BP] GO:0048878 | chemical homeostasis | ADRA2A, AKR1B1, ALOX12, APP, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, KCNH2, MET, TRPV1 | 2.07877 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH | 2.0707 |
[BP] GO:0072593 | reactive oxygen species metabolic process | ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1 | 2.06217 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH | 2.06026 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ADRA2A, ALOX15, APP, FLT3, HMGCR, IGF1R, KDR, KIT, PTPN1, SRC, XDH | 2.05659 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH | 2.02662 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, DNMT1, FABP3, HSD17B2, KDR, MMP2, SLC6A4, SRC | 2.02662 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, F3, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH | 2.01929 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.01929 |
[BP] GO:0006145 | None | AOX1, XDH | 2.01929 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.01929 |
[BP] GO:0046686 | response to cadmium ion | CYP1A2, KIT, MMP9, TERT | 2.01 |
[BP] GO:0044236 | multicellular organism metabolic process | MMP1, MMP12, MMP2, MMP9, TRPV1 | 2.00649 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DYRK1A, ESR1, HMGCR, IGF1R, MET, MMP9, PTPN1, SRC, XDH | 2.00268 |
[CC] GO:0044432 | endoplasmic reticulum part | APP, BACE1, BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, FLT3, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTPN1 | 3.66465 |
[CC] GO:0043227 | membrane-bounded organelle | ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 3.30352 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KCNH2, KDR, KIT, MMP2, MMP9, NR3C1, PIM1, PTPN1, PTPRS, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 3.13755 |
[CC] GO:0016020 | membrane | ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, KIT, MET, MMP2, PHF8, PIM1, PTPN1, PTPRS, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TRPV1, TYR | 2.67962 |
[CC] GO:0043226 | organelle | ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CBR1, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 2.42283 |
[CC] GO:0005886 | plasma membrane | ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CSNK2A1, ESR1, F3, FLT3, GBA2, GLO1, HCAR2, IGF1R, KCNH2, KDR, KIT, MET, MMP2, PIM1, PTPN1, PTPRS, SLC6A2, SLC6A4, SRC, TERT, TRPV1 | 2.21553 |
[CC] GO:0005789 | endoplasmic reticulum membrane | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2 | 2.179 |
[CC] GO:0005783 | None | ADORA1, APEX1, APP, BCL2, CA4, CES1, CES2, CYP19A1, FLT3, GBA2, HMGCR, KDR, PTPN1, XDH | 2.08688 |
[CC] GO:0043231 | intracellular membrane-bounded organelle | ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, APP, AURKB, BACE1, BCL2, CA4, CA5A, CA5B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, NR3C1, PHF8, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 2.01 |
[MF] GO:0046914 | transition metal ion binding | ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH | 22.9996 |
[MF] GO:0003824 | catalytic activity | ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, F3, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 17.7797 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 16.2618 |
[MF] GO:0043167 | ion binding | ABCB1, ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TUBB3, TYR, XDH | 16.1536 |
[MF] GO:0043169 | cation binding | ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, KIT, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 11.2171 |
[MF] GO:0046872 | metal ion binding | ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, KIT, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 10.9559 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PHF8, TYR, XDH | 10.5785 |
[MF] GO:0005506 | iron ion binding | ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, PHF8, XDH | 10.5785 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PPARA, PTPN1, RORC, TNKS | 10.5785 |
[MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.2595 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.1162 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 | 7.8512 |
[MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 | 7.50507 |
[MF] GO:0005496 | steroid binding | CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR3C1, RORC | 6.96735 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, TYR | 6.62515 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 6.54583 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 | 6.50305 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP3A4 | 6.29774 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, PHF8, TYR | 6.05244 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, SRC | 5.6106 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 5.51064 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP3A4 | 5.51064 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, SRC | 5.36082 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, HMGCR, HSD11B2, HSD17B1, SRC, XDH | 4.95616 |
[MF] GO:0008289 | lipid binding | ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, PPARA, RORC, TRPV1 | 4.76549 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.76217 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 4.67888 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 4.67888 |
[MF] GO:0008144 | drug binding | ABCB1, ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP3A4, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, PPARA, SLC6A4, SRC, TOP2A, TRPV1 | 4.49796 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, KIT, MET | 4.13216 |
[MF] GO:0042802 | identical protein binding | ACHE, ADRA2A, AOX1, APP, BCL2, CSNK2A1, DYRK1A, ESR1, ESR2, FLT3, HMGCR, IGF1R, KCNH2, KDR, KIT, MET, MMP9, SLC6A4, TERT, TOP2A, TRPV1, TYR, XDH | 3.83207 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, KIT, MET | 3.56205 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC | 3.53015 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, KIT, MET, NR3C1, PPARA, RORC, TRPV1 | 3.31127 |
[MF] GO:0019899 | enzyme binding | ADRA2A, APP, AURKB, BACE1, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRB, F3, HMGCR, KCNH2, KIT, MET, NR3C1, PPARA, PTPN1, SLC6A4, SRC, TNKS2, TOP2A | 3.3007 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.04079 |
[MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 2.99639 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KCNH2, KDR, KIT, MET, PIM1, SRC | 2.93787 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 2.93578 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, ADRA2A, AXL, CDK6, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, KIT, MET, NR3C1, PPARA, RORC, TRPV1 | 2.9234 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC | 2.8874 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, ADRA2A, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC | 2.73436 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, KIT, MET, NR3C1, PPARA, RORC, TRPV1 | 2.64101 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.64101 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.64101 |
[MF] GO:0047977 | hepoxilin-epoxide hydrolase activity | ALOX12, ALOX15 | 2.64101 |
[MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.64101 |
[MF] GO:0097159 | organic cyclic compound binding | ABCB1, ADORA1, ADRA2A, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, MMP12, NR3C1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TRPV1, TUBB3, XDH | 2.33356 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.32782 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KCNH2, KDR, KIT, MET, PIM1, SRC | 2.25333 |
[MF] GO:0008392 | None | CYP2A13, CYP2A6, CYP2C19 | 2.25333 |
[MF] GO:0008391 | None | CYP2A13, CYP2A6, CYP2C19 | 2.25333 |
[MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.25333 |
[MF] GO:0004052 | arachidonate 12-lipoxygenase activity | ALOX12, ALOX15 | 2.25333 |
[MF] GO:0005330 | None | SLC6A2, SLC6A4 | 2.25333 |
[MF] GO:0051120 | hepoxilin A3 synthase activity | ALOX12, ALOX15 | 2.25333 |
[MF] GO:0047374 | None | CES1, CES2 | 2.25333 |
[MF] GO:0042803 | protein homodimerization activity | ACHE, ADRA2A, AOX1, BCL2, FLT3, HMGCR, KCNH2, KIT, SLC6A4, TERT, TOP2A, TYR, XDH | 2.2187 |
[MF] GO:1901363 | heterocyclic compound binding | ABCB1, ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, MMP12, NR3C1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TRPV1, TUBB3, XDH | 2.179 |
[MF] GO:0036094 | small molecule binding | ABCB1, ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, TRPV1, TUBB3, XDH | 2.1729 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, KIT, MET, NR3C1, PPARA, RORC, TRPV1 | 2.15349 |
[MF] GO:0001223 | transcription coactivator binding | ESR1, PPARA, TERT | 2.08223 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.01929 |
[MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.01929 |
[MF] GO:0032795 | None | ADORA1, ADRA2A | 2.01929 |
[MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.01929 |
[MF] GO:0003674 | molecular_function | ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PHF8, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TUBB3, TYR, XDH | 2.00548 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 17.313 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 9.5438 |
Metabolic pathways_Homo sapiens_hsa01100 | DNMT1, ALOX15, AKR1B1, ALOX12, HMGCR, CYP3A4, CYP2C19, GBA2, CYP19A1, HSD11B1, FUT7, ALOX5, HSD17B1, HSD17B2, AOX1, XDH, FDPS, CBR1, TYR, CYP2A6, AKR1B10, CYP1A2, CYP1A1, ALPL, CES1 | 8.4427 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP2C19 | 8.4427 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 7.2596 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 7.4733 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | DNMT1, CDK6, ABCB1, BCL2, PIM1, CYP1B1, MMP9, MET, CDC25B | 3.9722 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, CYP3A4, XDH, CES2, CES1 | 4.4839 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, ALOX12, CYP2C19 | 3.9722 |
Serotonergic synapse_Homo sapiens_hsa04726 | APP, ALOX5, ALOX15, ALOX12, CYP2C19, SLC6A4 | 3.9311 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1, AOX1, CYP3A4 | 3.9311 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, ESR1, IGF1R | 3.5699 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, CYP1A2, AOX1, CYP3A4, CYP2C19 | 3.848 |
Pathways in cancer_Homo sapiens_hsa05200 | CDK6, FLT3, MMP1, MMP2, KIT, BCL2, MMP9, MET, IGF1R | 3.2909 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, CSNK2A1, SRC, MET, IGF1R | 3.7293 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4, CYP2C19 | 3.9722 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, ESR1, ESR2 | 3.2447 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, AOX1, CYP1B1 | 3.5802 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 3.5699 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2, BCL2, PIM1, F3 | 2.1774 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 2.7652 |
Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2, HMGCR, CYP3A4 | 2.7375 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, BCL2, MET, IGF1R | 1.9245 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, KIT, KDR, MET, IGF1R | 1.8604 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CDK6, KIT, KDR, BCL2, MET, IGF1R | 1.7226 |
Hepatitis B_Homo sapiens_hsa05161 | CDK6, SRC, BCL2, MMP9 | 1.7226 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, KIT, PIM1 | 1.9245 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KIT, KDR, MET, IGF1R | 1.6 |
Melanoma_Homo sapiens_hsa05218 | CDK6, MET, IGF1R | 1.7226 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, KIT, MET | 1.7577 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC, ESR1, ESR2 | 1.7226 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | ADORA3, ADORA1, TRPV1, NR3C1, ADRA2A | 1.5047 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.4836 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC, ALOX12, TRPV1 | 1.4584 |
Ras signaling pathway_Homo sapiens_hsa04014 | KIT, KDR, MET, IGF1R | 1.2108 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, BCL2, ADORA1 | 1.2545 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KIT, KDR, MET | 1.0426 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | BCL2, PIM1, AOX1 | 1.0154 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1, ADRA2A | 0.978 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HCAR2, ADORA1, PPARA | 0.8365 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1 | 1.0793 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.0426 |
Glioma_Homo sapiens_hsa05214 | CDK6, IGF1R | 1.0154 |
Prostate cancer_Homo sapiens_hsa05215 | BCL2, IGF1R | 0.8365 |
Small cell lung cancer_Homo sapiens_hsa05222 | CDK6, BCL2 | 0.8365 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 4.7652 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 0.7905 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 0.8324 |
Gap junction_Homo sapiens_hsa04540 | SRC, TUBB3 | 0.8365 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3, KIT | 0.8365 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 0.8972 |
Melanogenesis_Homo sapiens_hsa04916 | KIT, TYR | 0.7823 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, BCL2 | 0.7312 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.0566 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | BCL2, IGF1R | 0.7731 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 0.9884 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PPARA | 0.7383 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2 | 0.823 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, ESR1 | 0.7055 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, BCL2 | 0.7055 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.7055 |
AMPK signaling pathway_Homo sapiens_hsa04152 | HMGCR, IGF1R | 0.6817 |
Measles_Homo sapiens_hsa05162 | CDK6, CSNK2A1 | 0.639 |
Cell cycle_Homo sapiens_hsa04110 | CDK6, CDC25B | 0.6817 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.6349 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | ESRRB, IGF1R | 0.631 |
Alzheimer's disease_Homo sapiens_hsa05010 | BACE1, APP | 0.5367 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.52 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, BCL2 | 0.4697 |
MAPK signaling pathway_Homo sapiens_hsa04010 | CDC25B | 0.1665 |
Viral carcinogenesis_Homo sapiens_hsa05203 | CDK6, SRC | 0.465 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | SRC | 0.2067 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.24 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.2509 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2 | 0.2563 |
HTLV-I infection_Homo sapiens_hsa05166 | FDPS, TERT | 0.3892 |
Influenza A_Homo sapiens_hsa05164 | FDPS | 0.2509 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.24 |
Apoptosis_Homo sapiens_hsa04210 | BCL2 | 0.2903 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | BCL2 | 0.2831 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.2802 |
Phagosome_Homo sapiens_hsa04145 | TUBB3 | 0.2774 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC | 0.2729 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1 | 0.2903 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1 | 0.2892 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | KIT | 0.2882 |
FoxO signaling pathway_Homo sapiens_hsa04068 | IGF1R | 0.2997 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.2997 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.3146 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | BCL2 | 0.3156 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.3077 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3146 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.341 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.3665 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | IGF1R | 0.3805 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.3805 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC | 0.3888 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.3805 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.3882 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.3883 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.5047 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.3886 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.3885 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.3978 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6 | 0.4326 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.4117 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.4316 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.4439 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | IGF1R | 0.4577 |
Pancreatic cancer_Homo sapiens_hsa05212 | CDK6 | 0.4577 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.4577 |
p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.4451 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.4577 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.4633 |
Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, TYR | 1.4248 |
Colorectal cancer_Homo sapiens_hsa05210 | BCL2 | 0.4577 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.4577 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.4577 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | CDK6 | 0.4759 |
Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | TUBB3 | 0.4782 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.4778 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.412 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.5025 |
Malaria_Homo sapiens_hsa05144 | MET | 0.5133 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.52 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.5166 |
Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA2 | 0.52 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2 | 0.558 |
ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.5258 |
Cysteine and methionine metabolism_Homo sapiens_hsa00270 | DNMT1 | 0.5222 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.6977 |
Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.5532 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.634 |
Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.6196 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.639 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | FDPS, HMGCR | 1.7226 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.6714 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.6362 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.6619 |
Other glycan degradation_Homo sapiens_hsa00511 | GBA2 | 0.7731 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 0.8365 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.0792 |